Dark

Check out our API

NBSE
NeuBase Therapeutics, Inc. Common Stock
stock NASDAQ

Inactive

May 10, 2024

0.3780USD-3.201%(-0.0125)97,744

Pre-market

Dec 31, 1969 7:00:00 PM EST

0.00USD-100.000%(-0.39)0

After-hours

Dec 31, 1969 7:00:00 PM EST

0.00USD0.000%(0.00)0

OverviewHistoricalExchangesShortsTrends

NBSE Reddit Mentions

Subreddits

Limit Labels Price

We have sentiment values and mention counts going back to 2017. The complete data set is available via the API.

Take me to the API

NBSE Specific Mentions

As of May 12, 2025 1:05:52 AM EDT (<1 min. ago)

Includes all comments and posts. Mentions per user per ticker capped at one per hour.

218 days ago • u/Hefty-Lengthiness-20 • r/shroomstocks • mods_can_you_allow_for_free_respectable_speech • C

You mean it is performing like most other stocks?
—————//
“Give me ten random small cap biotech companies and their performance the last year (stock price only)”
Here are ten random small-cap biotech companies and their stock performance over the past year:
1. Aditxt (ADTX): -99.7%
2. SciSparc (SPRC): -94.2%
3. PainReform (PRFX): -96.6%
4. GRI Bio (GRI): -99.7%
5. Genprex (GNPX): -97.5%
6. Revelation Biosciences (REVB): -96.0%
7. NeuBase Therapeutics (NBSE): -90.2%
8. 180 Life Sciences (ATNF): -87.3%
9. Seelos Therapeutics (SEEL): -99.5%
10. Windtree Therapeutics (WINT): -94.8%
These companies have seen steep declines in their stock prices, with most losing over 90% of their value in the past year, reflecting the volatility of the biotech sector, especially among small-cap firms. High development costs, regulatory risks, and dependency on successful clinical trials often lead to significant price fluctuations.
Sources: Simply Wall St and Nasdaq.

sentiment -0.97

218 days ago • u/Hefty-Lengthiness-20 • r/shroomstocks • mods_can_you_allow_for_free_respectable_speech • C

You mean it is performing like most other stocks?
—————//
“Give me ten random small cap biotech companies and their performance the last year (stock price only)”
Here are ten random small-cap biotech companies and their stock performance over the past year:
1. Aditxt (ADTX): -99.7%
2. SciSparc (SPRC): -94.2%
3. PainReform (PRFX): -96.6%
4. GRI Bio (GRI): -99.7%
5. Genprex (GNPX): -97.5%
6. Revelation Biosciences (REVB): -96.0%
7. NeuBase Therapeutics (NBSE): -90.2%
8. 180 Life Sciences (ATNF): -87.3%
9. Seelos Therapeutics (SEEL): -99.5%
10. Windtree Therapeutics (WINT): -94.8%
These companies have seen steep declines in their stock prices, with most losing over 90% of their value in the past year, reflecting the volatility of the biotech sector, especially among small-cap firms. High development costs, regulatory risks, and dependency on successful clinical trials often lead to significant price fluctuations.
Sources: Simply Wall St and Nasdaq.

sentiment -0.97

Share